FMRFamide‐like peptides encoded on the flp‐18 precursor gene activate two isoforms of the orphan Caenorhabditis elegans G‐protein‐coupled receptor Y58G8A.4 heterologously expressed in mammalian cells

Two alternatively spliced variants of an orphan Caenorhabditis elegans G‐protein‐coupled receptors (GPCRs; Y58G8A.4a and Y58G8A.4b) were cloned and functionally expressed in Chinese hamster ovary (CHO) cells. The Y58G8A.4a and Y58G8A.4b proteins (397 and 433 amino acid residues, respectively) differ both in amino acid sequence and length of the C‐terminal tail of the receptor. A calcium mobilization assay was used as a read‐out for receptor function. Both receptors were activated, with nanomolar potencies, by putative peptides encoded by the flp‐18 precursor gene, leading to their designation as FLP‐18R1a (Y58G8A.4a) and FLP‐18R1b (Y58G8A.4b). Three Ascaris suum neuropeptides AF3, AF4, and AF20 all sharing the same FLP‐18 C‐terminal signature, ‐PGVLRF‐NH2, were also potent agonists. In contrast to other previously reported C. elegans GPCRs expressed in mammalian cells, both FLP‐18R1 variants were fully functional at 37°C. However, a 37 to 28°C temperature shift improved their activity, an effect that was more pronounced for FLP‐18R1a. Despite differences in the C‐terminus, the region implicated in distinct G‐protein recognition for many other GPCRs, the same signaling pathways were observed for both Y58G8A.4 isoforms expressed in CHO cells. Gq protein coupling seems to be the main but not the exclusive signaling pathway, because pretreatment of cells with U‐73122, a phospholipase inhibitor, attenuated but did not completely abolish the Ca2+ signal. A weak Gs‐mediated receptor activation was also detected as reflected in an agonist‐triggered concentration‐dependent cAMP increase. The matching of the FLP‐18 peptides with their receptor(s) allows for the evaluation of the pharmacology of this system in the worm in vivo. © 2007 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 90: 339–348, 2008.

[1]  M. Kozak An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. , 1987, Nucleic acids research.

[2]  F. Fitzpatrick,et al.  Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. , 1990, The Journal of pharmacology and experimental therapeutics.

[3]  A. R. Friedman,et al.  The pharmacology of FMRFamide-related neuropeptides in nematodes: new opportunities for rational anthelmintic discovery? , 1995, International journal for parasitology.

[4]  L. Holden-Dye,et al.  The effects of the peptides AF3 (AVPGVLRFamide) and AF4 (GDVPGVLRFamide) on the somatic muscle of the parasitic nematodes Ascaris suum and Ascaridia galli , 1997, Parasitology.

[5]  J. Thompson,et al.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. , 1997, Nucleic acids research.

[6]  L. Holden-Dye,et al.  The role of cAMP in the actions of the peptide AF3 in the parasitic nematodes Ascaris suum and Ascaridia galli. , 1998, Molecular and biochemical parasitology.

[7]  Kyuhyung Kim,et al.  FMRFamide-related neuropeptide gene family in Caenorhabditis elegans , 1999, Brain Research.

[8]  T. Geary,et al.  Nematode neuropeptide modulation of the vagina vera of Ascaris suum: in vitro effects of PF1, PF2, PF4, AF3 and AF4 , 2000, Parasitology.

[9]  Anthony C Chiulli,et al.  A Novel High Throughput Chemiluminescent Assay for the Measurement of Cellular Cyclic Adenosine Monophosphate Levels , 2000, Journal of biomolecular screening.

[10]  T. Kubiak,et al.  Type A allatostatins from Drosophila melanogaster and Diplotera puncata activate two Drosophila allatostatin receptors, DAR-1 and DAR-2, expressed in CHO cells. , 2001, Biochemical and biophysical research communications.

[11]  C. Li,et al.  Isolation and preliminary biological assessment of AADGAPLIRFamide and SVPGVLRFamide from Caenorhabditis elegans. , 2001, Biochemical and biophysical research communications.

[12]  D. P. Thompson,et al.  Neuropeptide signaling systems - potential drug targets for parasite and pest control. , 2002, Current topics in medicinal chemistry.

[13]  C. Bannow,et al.  Cloning and functional expression of the first Drosophila melanogaster sulfakinin receptor DSK-R1. , 2002, Biochemical and biophysical research communications.

[14]  T. Kubiak,et al.  Functional Annotation of the Putative Orphan Caenorhabditis elegans G-protein-coupled Receptor C10C6.2 as a FLP15 Peptide Receptor* , 2003, Journal of Biological Chemistry.

[15]  T. Kubiak,et al.  Differential Activation of “Social” and “Solitary” Variants of the Caenorhabditis elegans G Protein-coupled Receptor NPR-1 by Its Cognate Ligand AF9* , 2003, Journal of Biological Chemistry.

[16]  Mario de Bono,et al.  Inhibition of Caenorhabditis elegans social feeding by FMRFamide-related peptide activation of NPR-1 , 2003, Nature Neuroscience.

[17]  T. Geary,et al.  The changing landscape of antiparasitic drug discovery for veterinary medicine. , 2004, Trends in parasitology.

[18]  W. Luyten,et al.  Functional characterization of the putative orphan neuropeptide G‐protein coupled receptor C26F1.6 in Caenorhabditis elegans , 2004, FEBS letters.

[19]  A. Stretton,et al.  Mass spectrometric map of neuropeptide expression in Ascaris suum , 2005, The Journal of comparative neurology.

[20]  L. Schoofs,et al.  Characterization of an RFamide‐Related Peptide Orphan GPCR in C. elegans , 2005, Annals of the New York Academy of Sciences.

[21]  S. Husson,et al.  Discovering neuropeptides in Caenorhabditis elegans by two dimensional liquid chromatography and mass spectrometry. , 2005, Biochemical and biophysical research communications.

[22]  T. Geary,et al.  Analysis of FMRFamide-like peptide (FLP) diversity in phylum Nematoda. , 2005, International journal for parasitology.

[23]  T. Geary,et al.  Neuropeptide G-protein-coupled receptors, their cognate ligands and behavior in Caenorhabditis elegans. , 2005, Trends in pharmacological sciences.

[24]  T. Geary,et al.  Nematode neuropeptide receptors and their development as anthelmintic screens , 2005, Parasitology.

[25]  L. Schoofs,et al.  Molecular characterization of two G protein-coupled receptor splice variants as FLP2 receptors in Caenorhabditis elegans. , 2005, Biochemical and biophysical research communications.

[26]  C. Li,et al.  The ever-expanding neuropeptide gene families in the nematode Caenorhabditis elegans , 2005, Parasitology.

[27]  L. Schoofs,et al.  FMRFamide related peptide ligands activate the Caenorhabditis elegans orphan GPCR Y59H11AL.1 , 2006, Peptides.

[28]  Liliane Schoofs,et al.  Defective processing of neuropeptide precursors in Caenorhabditis elegans lacking proprotein convertase 2 (KPC‐2/EGL‐3): mutant analysis by mass spectrometry , 2006, Journal of neurochemistry.

[29]  T. Geary,et al.  The FLP-side of nematodes. , 2006, Trends in parasitology.

[30]  C. Fleming,et al.  flp gene disruption in a parasitic nematode reveals motor dysfunction and unusual neuronal sensitivity to RNA interference , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.